Scarica l'app Stockscreener
0.5023
0.42%
0.0021
Oncolytics Biotech Inc Borsa (ONCY) Ultime notizie
Form 8K Oncolytics Biotech Inc. For: 20 October By Investing.com - Investing.com Nigeria
Oncolytics Biotech Inc - Baystreet.ca
Oncolytics Biotech Inc - Baystreet.ca
Form 8K Oncolytics Biotech Inc. For: 20 October By Investing.com - Investing.com India
A colon cancer trial with 30 patients per arm anchors Oncolytics (ONCY)'s planned congress poster. - Stock Titan
Oncolytics Biotech Inc - Baystreet.ca
Oncolytics Biotech Inc - Baystreet.ca
Oncolytics Biotech Inc - Baystreet.ca
Oncolytics Biotech Inc - Baystreet.ca
Oncolytics Biotech Inc - Baystreet.ca
Patent protection for Oncolytics’ cancer therapy could extend into the late 2040s. - Stock Titan
Form DEF 14A CG Oncology Inc For: 11 October By Investing.com - Investing.com Nigeria
Form DEF 14A CG Oncology Inc For: 11 October By Investing.com - Investing.com South Africa
Form DEF 14A CG Oncology Inc For: 11 October By Investing.com - Investing.com India
Oncolytics Biotech Announces November 19, 2026 Annual Stockholder Meeting and Proxy Details - Kalkine Media
Two directors aren't standing for reelection at Oncolytics Biotech (ONCY)'s November 19 meeting. - Stock Titan
TRex Bio Files for Nasdaq IPO - Yahoo! Finance Canada
Oncolytics Biotech (Nasdaq:ONCY)Stock Analysis - Simply Wall Street
Pyxis Oncology stock falls on public offering announcement - Yahoo! Finance Canada
Form 8K Oncolytics Biotech Inc. For: 29 September By Investing.com - Investing.com South Africa
Form 8K Oncolytics Biotech Inc. For: 29 September By Investing.com - Investing.com Nigeria
Form 8K Oncolytics Biotech Inc. For: 29 September By Investing.com - Investing.com Canada
Form 8K Oncolytics Biotech Inc. For: 28 September By Investing.com - Investing.com Nigeria
Oncolytics Biotech Inc - Baystreet.ca
Oncolytics Biotech Inc - Baystreet.ca
Oncolytics Biotech (NasdaqCM:ONCY) Stock Forecast & Analyst Predictions - Simply Wall Street
Stocks In Play - baystreet.ca
Oncolytics Biotech Stock Price Forecast. Should You Buy ONCY? - StockInvest.us
Neonc Technologies Holdings, Briacell Therapeutics and Oncolytics Biotech Have Report Clinical and Regulatory Developments Across Brain, Breast and Colorectal Cancer - marketscreener.com
Oncolytics Biotech Inc - Baystreet.ca
Oncolytics (ONCY) Reports Promising Preclinical Data on Pelareor - GuruFocus
Oncolytics reports preclinical data on pelareorep with RAS inhibitor - investing.com
Oncolytics reports preclinical data on pelareorep with RAS inhibitor By Investing.com - Investing.com India
An experimental cancer treatment combination reduced tumor growth in early tests - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Oncolytics Biotech Inc.ADR Key Financial Ratios – Valuation, Profitability & More - Value Research
Zacks Research Issues Pessimistic Forecast for ONCY Earnings - MarketBeat
ONCY: FDA Provides Alignment on Registrational Pathway for Pelareorep in CRC - Yahoo Finance
Could Oncolytics Biotech (TSX:ONC) Reach Its Next Clinical Milestone? - Kalkine Media
Can Oncolytics Biotech (TSX:ONC) Unlock Its Next Catalyst? - Kalkine Media
HC Wainwright Has Bearish Estimate for ONCY FY2026 Earnings - MarketBeat
ONCY Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus
Oncolytics Biotech (NASDAQ:ONCY) Price Target Cut to $5.00 by Analysts at HC Wainwright - MarketBeat
H.C. Wainwright cuts Oncolytics Biotech price target to $5 on pipeline shift - Investing.com Canada
H.C. Wainwright cuts Oncolytics Biotech price target to $5 on pipeline shift - Investing.com
H.C. Wainwright cuts Oncolytics Biotech price target to $5 on pipeline shift - Investing.com
H.C. Wainwright Maintains Oncolytics Biotech(ONCY.US) With Buy Rating, Cuts Target Price to $5 - Moomoo
Why Oncolytics Biotech Just Cleared A Hurdle That Stalls Most Cancer Trials - Yahoo Finance
BRIEF-Oncolytics Biotech® Aligns With FDA On Registrational Path For Second-Line Ras-Mutant Mss Colorectal Cancer - Bitget
Oncolytics Biotech (ONCY) Advances Pelareorep Trial with Positiv - GuruFocus
3.09%
0.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):